Once-weekly basal insulin combined with an intermittently scanned continuous glucose monitor reduced HbA1c and improved time ...

The following is a summary of “Evidence for improved glucose metrics and perinatal outcomes with continuous glucose ...

Type 2 diabetes medications include metformin, sulfonylureas, alpha-glucosidase inhibitors, and other medications that change ...

Science Connected Magazine is an editorially independent, non-profit newsroom producing open-access science journalism and ...

A survey conducted by the continuous glucose monitor maker Dexcom found that just over half of healthcare providers ranked technology and education as having larger impacts when it comes to ...

Treatments for Type 2 diabetes and new clinical trial data on ... The new device would give Dexcom a CGM that can be worn for as long as competitor Abbott’s Freestyle Libre 3 Plus sensor.

The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

A comprehensive digital approach to helping patients manage type 2 diabetes, combining continuous glucose monitoring (CGM) devices, wearables and a mobile app, has been shown to improve metabolic ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people with insulin-treated type 2 diabetes (T2D), a new randomized trial showed.

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. First, let me ...

Testing your blood sugar gives you important information about how well your type 2 diabetes management and ... may use a continuous glucose monitor (CGM), which uses a sensor placed under the ...